An experimental drug that has been studied for nearly 20 years continues to show effectiveness in about half of the patients who participated in a recent phase 2 clinical trial. The drug, Teplizumab -- also known as anti CD3, is designed to block the advance of type 1 diabetes in its earliest stages.
Mark Anderson, MD, PhD, and his colleagues have discovered a distinctive type of immune cell called an eTAC, which puts a damper on immune responses and could eventually lead to more effective treatments for autoimmune diseases including type 1 diabetes.
Coursera, one of the leading providers of MOOCs (or massive open online courses) is now offering a free course on diabetes taught by faculty members from throughout UCSF’s professional schools: Medicine, Nursing, Pharmacy and Dentistry.
RNA specialist, Michael McManus, PhD, received an NIH grant to explore and enhance our understanding of a recently discovered cell-to-cell messaging process called extracellular (outside the cell) RNA communication -- exRNA.
Feroz Papa, MD, PhD, was named a 2013 Harrington Scholar-Innovator by the Harrington Discovery Institute’s Scientific Advisory Board from a field of more than 130 applicants from 53 institutions.
Four prevention trials are currently under way at dozens of sites around the country, including both Stanford and UCSF. Click here to read the article.
After years of legal and legislative challenges, the American Diabetes Association and DREDF won their battle to support California students with diabetes. The California Supreme Court ruled that children may receive insulin from trained volunteers without having to wait for a school nurse. <ADA Story>
This month, Dean Schillinger, MD, was awarded the 2013 Public Health Communications Research Award by the American Public Health Association (APHA). The APHA Everett Rogers Award is given to an individual who has made an outstanding contribution to advancing the study and/or practice of public health communication.
UCSF researchers have indentified a type of immune cell that appears to put a damper on the body's immune response. Click here to read this article.